Polymorphisms of the TNFAIP3 region and Graves' disease

Autoimmunity

Volumn 47, Issue 7, 2014, Pages 459-465

  Song, Rong Hua ^a   Yu, Zhi Yun ^b   Wang, Qiong ^a,c   Muhali, Fatuma Said ^a,c   Jiang, Wen Juan ^c   Xiao, Ling ^c   Shi, Xiao Hong ^c   He, Shuang Tao ^c   Xu, Jian ^c   Zhang, Jin An ^c  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b Xi'an Health School   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

Autoimmune thyroid disease; Disease; Graves'; Hashimoto's thyroiditis; Single nucleotide polymorphism; Tumor necrosis factor induced protein 3

Indexed keywords

TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR AIP3; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; NUCLEAR PROTEIN; SIGNAL PEPTIDE; TNFAIP3 PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; CHINESE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; GRAVES DISEASE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PATHOGENESIS; PHENOTYPE; PROTEIN EXPRESSION; RISK ASSESSMENT; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; THYROID WEIGHT; ASIAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION; GENETICS; HASHIMOTO DISEASE;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; DNA-BINDING PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84906262984     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2014.914504     Document Type: Article

References (33)

1. Tomer, Y., and T. F. Davies. 2003. Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr. Rev. 24: 694-717
2. Ban, Y., T. Tozaki, M. Taniyama, et al. Multiple SNPs in intron 41 of thyroglobulin gene are associated with autoimmune thyroid disease in the Japanese population. PLoS One 7: e37501
3. Maierhaba, M., J. A. Zhang, Z. Y. Yu, et al. 2008. Association of the thyroglobulin gene polymorphism with autoimmune thyroid disease in Chinese population. Endocrine 33: 294-299
4. Hsiao, J. Y., M. C. Hsieh, C. T. Hsiao, et al. 2008. Association of CD40 and thyroglobulin genes with later-onset Graves' disease in Taiwanese patients. Eur. J. Endocrinol. 159: 617-621
5. Liu, L., H. Q. Wu, Q. Wang, et al. 2012. Association between thyroid stimulating hormone receptor gene intron polymorphisms and autoimmune thyroid disease in a Chinese Han population. Endocr. J. 59: 717-723
6. Brand, O. J., J. C. Barrett, M. J. Simmonds, et al. 2009. Association of the thyroid stimulating hormone receptor gene (TSHR) with Graves' disease. Hum. Mol. Genet. 18: 1704-1713
7. Zeitlin, A. A., J. M. Heward, P. R. Newby, et al. 2008. Analysis of HLA class II genes in Hashimoto's thyroiditis reveals differences compared to Graves' disease. Genes Immun. 9: 358-363
8. Cho, W. K., M. H. Jung, E. J. Choi, et al. Association of HLA alleles with autoimmune thyroid disease in Korean children. Horm. Res. Paediatr. 76: 328-334
9. Kavvoura, F. K., T. Akamizu, T. Awata, et al. 2007. Cytotoxic T-lymphocyte associated antigen 4 gene polymorphisms and autoimmune thyroid disease: a meta-Analysis. J. Clin. Endocrinol. Metab. 92: 3162-3170
10. Zhao, S. X., C. M. Pan, H. M. Cao, et al. Association of the CTLA4 gene with Graves' disease in the Chinese Han population. PLoS One 5: e9821
11. Kalantari, T., H. Mostafavi, A. M. Pezeshki, et al. 2003. Exon-1 polymorphism of ctla-4 gene in Iranian patients with Graves' disease. Autoimmunity 36: 313-316
12. Ban, Y., T. Tozaki, M. Taniyama, and M. Tomita. 2005. Association of a CTLA-4 30 untranslated region (CT60) single nucleotide polymorphism with autoimmune thyroid disease in the Japanese population. Autoimmunity 38: 151-153
13. Heward, J. M., O. J. Brand, J. C. Barrett, et al. 2007. Association of PTPN22 haplotypes with Graves' disease. J. Clin. Endocrinol. Metab. 92: 685-690
14. Chung, S. A., and L. A. Criswell. 2007. PTPN22: its role in SLE and autoimmunity. Autoimmunity 40: 582-590
15. Li, M., H. Sun, S. Liu, et al. CD40 C/T-1 polymorphism plays different roles in Graves' disease and Hashimoto's thyroiditis: a meta-Analysis. Endocr. J. 59: 1041-1050
16. Ban, Y., T. Tozaki, M. Taniyama, and M. Tomita. 2006. Association of a C/T single-nucleotide polymorphism in the 50 untranslated region of the CD40 gene with Graves' disease in Japanese. Thyroid 16: 443-446
17. Yan, N., Y. L. Yu, J. Yang, et al. 2012. Association of interleukin-17A and -17F gene single-nucleotide polymorphisms with autoimmune thyroid diseases. Autoimmunity 45: 533-539
18. Gu, L. Q., W. Zhu, S. X. Zhao, et al. 2010. Clinical associations of the genetic variants of CTLA-4, Tg, TSHR, PTPN22, PTPN12 and FCRL3 in patients with Graves' disease. Clin. Endocrinol. (Oxf) 72: 248-255
19. Beyaert, R., K. Heyninck, and S. Van Huffel. 2000. A20 and A20-binding proteins as cellular inhibitors of nuclear factor-kappa B-dependent gene expression and apoptosis. Biochem. Pharmacol. 60: 1143-1151
20. Heyninck, K., and R. Beyaert. 2005. A20 inhibits NF-kappaB activation by dual ubiquitin-editing functions. Trends Biochem. Sci. 30: 1-4
21. Lee, E. G., D. L. Boone, S. Chai, et al. 2000. Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science 289: 2350-2354
22. Bowes, J., R. Lawrence, S. Eyre, et al. 2010. Rare variation at the TNFAIP3 locus and susceptibility to rheumatoid arthritis. Hum. Genet. 128: 627-633
23. Dieguez-Gonzalez, R., M. Calaza, E. Perez-Pampin, et al. 2009. Analysis of TNFAIP3, a feedback inhibitor of nuclear factor-kappaB and the neighbor intergenic 6q23 region in rheumatoid arthritis susceptibility. Arthritis Res. Ther. 11: R42. doi:10.1186/ar2650
24. Orozco, G., A. Hinks, S. Eyre, et al. 2009. Combined effects of three independent SNPs greatly increase the risk estimate for RA at 6q23. Hum. Mol. Genet. 18: 2693-2699
25. Wang, K., R. Baldassano, H. Zhang, et al. 2010. Comparative genetic analysis of inflammatory bowel disease and type 1 diabetes implicates multiple loci with opposite effects. Hum. Mol. Genet. 19: 2059-2067
26. Musone, S. L., K. E. Taylor, T. T. Lu, et al. 2008. Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus. Nat. Genet. 40: 1062-1064
27. Graham, R. R., C. Cotsapas, L. Davies, et al. 2008. Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus. Nat. Genet. 40: 1059-1061
28. Dieude, P., M. Guedj, J. Wipff, et al. 2010. Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian population. Ann. Rheum. Dis. 69: 1958-1964
29. Vereecke, L., R. Beyaert, and G. van Loo. 2009. The ubiquitinediting enzyme A20 (TNFAIP3) is a central regulator of immunopathology. Trends Immunol. 30: 383-391
30. Chu, X., C. M. Pan, S. X. Zhao, et al. A genome-wide association study identifies two new risk loci for Graves' disease. Nat. Genet. 43: 897-901
31. Musone, S. L., K. E. Taylor, J. Nititham, et al. 2011. Sequencing of TNFAIP3 and association of variants with multiple autoimmune diseases. Genes Immun. 12: 176-182
32. Verstrepen, L., K. Verhelst, G. van Loo, et al. 2010. Expression, biological activities and mechanisms of action of A20 (TNFAIP3). Biochem. Pharmacol. 80: 2009-2020
33. Wertz, I. E., K. M. O'Rourke, H. Zhou, et al. 2004. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 430: 694-699